Ipca Laboratories Ltd (BOM:524494)
₹ 1557.15 25.65 (1.67%) Market Cap: 395.06 Bil Enterprise Value: 400.99 Bil PE Ratio: 68.50 PB Ratio: 6.24 GF Score: 91/100

Q2 2022 IPCA Laboratories Ltd Earnings Call Hosted by Dam Capital Advisors Ltd Transcript

Nov 16, 2021 / 10:00AM GMT
Release Date Price: ₹1077.43 (-2.03%)
Operator

Ladies and gentlemen, good day, and welcome to the Q2 FY '22 Earnings Conference Call of Ipca Laboratories Limited hosted by DAM Capital Advisors Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Nitin Agarwal from DAM Capital. Thank you. And over to you, sir.

Nitin Agarwal
DAM Capital Advisors Limited, Research Division - Head of Research

Hi. Thanks. And good afternoon everyone and a very warm welcome to Ipca Lab's Q2 FY '22 Results Earnings Call hosted by DAM Capital Advisors. On the call today we have representing Ipca management team, Mr. A.K. Jain, Joint Managing Director; and Mr. Harish Kamath, [CMP General Company Secretary]. I hand over a call to Mr. Jain to make some opening comments. And then we will leave the floor open for questions. So Jain, Please go ahead, sir.

Ajit Kumar Bhanwarlal Jain
Ipca Laboratories Limited - CFO, Joint MD & Executive Director

Okay. Thanks, Nitin, and DAM Capital Advisors for organizing this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot